Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.67
Delayed Data
As of Dec 02
 0.00 / 0.00%
Today’s Change
1.49
Today|||52-Week Range
2.85
-20.10%
Year-to-Date
Institutional investors purchased a net $86.4 thousand shares of NVGN during the quarter ended June 2016 and now own 1.88% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Other institutional1.87%
Mutual fund holders0.01%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

9/30/2016MORGAN STANLEY & CO. LLC  Bought 34.9 Thousand shares of Novogen Ltd
9/30/2016KCG AMERICAS LLC  Bought 23.7 Thousand shares of Novogen Ltd
9/30/2016CITADEL ADVISORS LLC  Bought 17.6 Thousand shares of Novogen Ltd

Top 10 Owners of Novogen Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Renaissance Technologies LLC0.74%137,300211,44200.00%
Bank of America, NA (Private Bank...0.48%88,822136,78600.00%
Morgan Stanley & Co. LLC0.33%60,70093,478+34,900+135.27%
KCG Americas LLC0.13%23,73836,557+23,738--
Citadel Advisors LLC0.09%17,64627,175+17,646--
Cornerstone Wealth Management LLC...0.07%13,23020,374+13,230--
Morgan Stanley Smith Barney LLC (...0.02%3,0184,64800.00%
UBS Securities LLC0.02%3,0004,620-2,990-49.92%
Marketocracy Capital Management L...0.01%2,6004,00400.00%
UBS Financial Services, Inc.0.00%8371,28900.00%

Top 10 Mutual Funds Holding Novogen Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Marketocracy Masters 100 Fund0.01%2,6004,00400.00%